贝泰妮:云南贝泰妮生物科技集团股份有限公司2023年年度报告英文版

【摘要】 YunnanBotaneeBio-TechnologyGroupCo.,Ltd.2023AnnualReport YunnanBotaneeBio-TechnologyGroupCo.,Ltd. 2023AnnualReport 20...

Yunnan Botanee Bio-Technology Group Co., Ltd.                                                  2023 Annual Report
    Yunnan Botanee Bio-Technology Group Co., Ltd.

                      2023 Annual Report

                                          2024-011

                          April, 2024


Yunnan Botanee Bio-Technology Group Co., Ltd.                                                  2023 Annual Report
            2023 Annual Report

    Section I Important Notice, Table of Contents, and Definitions

  Our Board of Directors, Board of Supervisors, directors, supervisors, and
senior managers guarantee that this annual report is true, accurate and complete
without falsehoods, misleading statements or major omissions, and undertake
individual and joint legal liabilities arising therefrom.

  Our Chairman and President Mr. Guo Zhenyu, CFO Mr. Wang Long, and
Head of Accounting Department Mr. Liu Zhaofeng hereby declare that the
financial statements herein are true, accurate, and complete.

    All directors of Botanee have attended the board meeting for deliberating on
this report.

    Forward-looking statements herein on Botanee’s future prospects, business
plans, etc. do not constitute substantial commitments to investors. Investors are
advised to read carefully such information, and watch investment risks. Investors
and related parties should maintain adequate risk awareness, and understand
the differences between plans, forecasts, and commitments.

    We have described in detail possible risks in our operations and our
countermeasures in “Section III Management Discussion and Analysis” and
“Section XI Future Prospects of Botanee” of this report. Investors are kindly
requested to pay attention to these sections.


Yunnan Botanee Bio-Technology Group Co., Ltd.                                                  2023 Annual Report
    Our profit-sharing plan deliberated on and adopted by the Board of
Directors is: to distribute CNY6.00 of cash dividend for every 10 shares to all
shareholders based on 420,605,382 shares, give them 0 bonus shares (tax
included), and issue 0 shares for them for every 10 shares by transferring capital
reserve.


Yunnan Botanee Bio-Technology Group Co., Ltd.                                                  2023 Annual Report
                      Table of Contents


Section I Important Notice, Table of Contents, and Definitions...... 2

Section II Company Profile and Key Financial Indicators ...... 10

Section III Discussion and Analysis by the Management ...... 15

Section IV Corporate Governance...... 60

Section V Environmental and Social Responsibility...... 81

Section VI Significant Events...... 82

Section VII Changes in Shares and Information about Shareholders...... 111

SectionIV Share Repurchases during the Reporting Period...... 115

Section VIII Preference Shares...... 117
Section IX Bonds...... 118
Section X Financial Report...... 119

Yunnan Botanee Bio-Technology Group Co., Ltd.                                                  2023 Annual Report
                Documents Available for Inspection

  (1) The original of our 2023 Annual Report signed by the Company’s legal representative Mr. Guo Zhenyu.

    (2) The financial statements signed and sealed by the Company’s legal representative Mr. Guo Zhenyu, CFO Mr. Wang Long,
and Head of Accounting Department Mr. Liu Zhaofeng, the person in charge of the accounting firm (Accounting Supervisor).

    (3) The original of our audit report sealed by Talent Certified Public Accountants (Special General Partnership), and signed

and sealed by its certified public accountants.

    4) The original of all our documents and announcements that have been publicly disclosed during the reporting period.

  The above documents are kept at our Board Secretary’s Office.


Yunnan Botanee Bio-Technology Group Co., Ltd.                                                  2023 Annual Report
                          Definitions

          Term                                                Definition

 CSRC                      China Securities Regulatory Commission

 SZSE                      Shenzhen Stock Exchange

 The Company/Botanee          Yunnan Botanee Bio-Technology Group Co., Ltd.

 Botanee Co., Ltd.              Kunming Botanee Bio-Technology Co., Ltd., the predecessor of Botanee

 Shanghai Botanee              Shanghai Botanee Bio-Technology Co., Ltd., a wholly-owned subsidiary of Botanee

 Beixiaoni (Shanghai)          Beixiaoni (Shanghai) Technology Co., Ltd., a wholly-owned subsidiary of Shanghai Botanee

 Yanyao Medical Management    Yanyao (Shanghai) Medical Management Co., Ltd., a wholly-owned subsidiary of Shanghai

                            Botanee

 Yanyao Medical Beauty        Shanghai Yanyao Medical Beauty Clinic Co., Ltd., a wholly-owned subsidiary of Yanyao

                            Medical Man